← The Wire
GHRSNasdaq
GH Research PLC
Pharmaceutical Preparations · L2 · CIK 1855129
GH Research PLC develops mebufotenin therapies for treatment-resistant depression
$1.45B
Market cap
$28.49
Last close
+1.0%
1D
+29.0%
5D
229K
Volume
Price · last 39 sessions+31.4%
May 4L $19.98 · H $28.49Jun 29
120
Total filings
Jun 26, 2026
Last filing
12/31
Fiscal year end
6-K6-KJun 26, 20266-K6-KJun 4, 20266-K6-KMay 21, 20266-K6-KMay 14, 2026424B5424B5May 14, 20266-K6-KMay 14, 20266-K6-KMay 13, 20266-K6-KMay 13, 20266-K6-KApr 30, 2026424B5424B5Apr 29, 20266-K6-KMar 25, 20266-K6-KMar 16, 202620-F20-FMar 5, 20266-K6-KMar 5, 20266-K6-KJan 22, 20266-K6-KJan 15, 20266-K6-KJan 13, 20266-K6-KJan 8, 20266-K6-KJan 5, 20266-K6-KJan 2, 20266-K6-KNov 24, 20256-K6-KNov 7, 20256-K6-KNov 6, 20256-K6-KOct 17, 20256-K6-KOct 14, 20256-K6-KOct 10, 20256-K6-KOct 9, 20256-K6-KSep 12, 20256-K6-KSep 9, 20256-K6-KAug 29, 20256-K6-KAug 7, 20256-K6-KAug 1, 20256-K6-KJul 23, 20256-K6-KJun 20, 20256-K6-KJun 18, 20256-K6-KJun 13, 20256-K6-KMay 27, 20256-K6-KMay 21, 20256-K6-KMay 15, 20256-K6-KMay 8, 202520-F20-FFeb 27, 20256-K6-KFeb 27, 20256-KFORM 6-KFeb 6, 2025424B5424B5Feb 5, 20256-KFORM 6-KFeb 5, 2025424B5424B5Feb 3, 20256-KFORM 6-KFeb 3, 20256-K6-KFeb 3, 20256-KFORM 6-KFeb 3, 20256-KFORM 6-KJan 31, 20256-K6-KJan 10, 20256-K6-KDec 5, 20246-K6-KNov 14, 20246-K6-KSep 20, 20246-K6-KSep 16, 20246-K6-KSep 9, 20246-K6-KSep 3, 20246-K6-KSep 3, 20246-K6-KSep 3, 20246-K6-KJun 28, 20246-K6-KJun 24, 20246-K6-KMay 15, 20246-K6-KMay 3, 20246-K6-KApr 10, 20246-K6-KMar 15, 202420-F20-FMar 7, 20246-K6-KFeb 29, 2024SC 13GGH RESEARCH PLCFeb 16, 2024SC 13GGH RESEARCH PLCFeb 14, 20246-K6-KJan 18, 20246-K6-KJan 5, 20246-KFORM 6-KNov 13, 20236-K6-KNov 9, 20236-K6-KOct 6, 20236-KFORM 6-KSep 29, 20236-KFORM 6-KSep 20, 20236-KFORM 6-KSep 1, 20236-K6-KAug 23, 20236-K6-KJul 19, 20236-KFORM 6-KJun 21, 2023
Similar companies
Comparable business profile · signals at a glance